☆ 4.7 Letter

Integration between oncology and palliative care: does one size fit all?

ANNALS OF ONCOLOGY (2016)

Journal

ANNALS OF ONCOLOGY

Volume 27, Issue 3, Pages 549-549

Publisher

OXFORD UNIV PRESS

DOI: 10.1093/annonc/mdv582

Keywords

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

One Size Does Not Fit All: Breast Cancer in Young Women

Lamis Yehia, Charis Eng

Summary: The study of characteristics of breast cancer in young women has important implications for personalized genomics-driven management.

CLINICAL CANCER RESEARCH (2022)

Add to Collection

Editorial Material Biochemistry & Molecular Biology

Ion channel auxiliary subunit: does one size fit all?

Izhar Karbat, Eitan Reuveny

Summary: Ion channels can adjust their activity by incorporating auxiliary subunits, and this study reveals that a voltage-gated K+ channel auxiliary subunit can also modulate the gating of Ca2+-activated Cl- channels.

CELL (2021)

Add to Collection

Review Health Care Sciences & Services

CFTR Modulators: Does One Dose Fit All?

Renske van der Meer, Erik B. Wilms, Harry G. M. Heijerman

Summary: CFTR modulators show strong treatment effects in specific mutation pwCF populations, but individual responses vary. Reconsidering dosing regimens can improve treatment responses and prevent side effects, but further research is needed to fully understand the pharmacokinetic properties and dosage responses.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Add to Collection

Review Ophthalmology

DMEK graft: One size does not fit all

Mohit Parekh, Davide Romano, Rintra Wongvisavavit, Giulia Coco, Giuseppe Giannaccare, Stefano Ferrari, Carlos Rocha-de-Lossada, Hannah J. Levis, Francesco Semeraro, Marina Rodriguez Calvo-de-Mora, Vincenzo Scorcia, Vito Romano

Summary: Descemet membrane endothelial keratoplasty (DMEK) is a popular surgical procedure for treating Fuchs endothelial corneal dystrophy (FECD) and pseudophakic bullous keratopathy (PBK). The size of the graft is crucial for the success of the procedure, with smaller grafts being preferred. However, larger diameter grafts pose challenges due to higher detachment rates.

ACTA OPHTHALMOLOGICA (2023)

Add to Collection

Article Obstetrics & Gynecology

Con: freeze-all for all? One size does not fit all

Lan N. Vuong

Summary: Freeze-all strategy has emerged as an alternative approach in in vitro fertilization (IVF) to reduce the negative effects of controlled ovarian stimulation. However, current studies have inconsistent results and a personalized approach should be taken based on individual patient characteristics and preference.

HUMAN REPRODUCTION (2022)

Add to Collection

Review Microbiology

Herpesviruses and Inflammasomes: One Sensor Does Not Fit All

Ayush Kumar, Georgia Stavrakis, Andrew H. Karaba

Summary: Herpesviruses are common DNA viruses that cause lifelong infections and are associated with various diseases. While they can evade the immune system, they are recognized by the innate immune system, leading to inflammation. Recent studies have found that inflammasome signaling plays a role in herpesvirus innate immune activation and impacts disease outcomes.

MBIO (2022)

Add to Collection

Review Microbiology

Herpesviruses and Inflammasomes: One Sensor Does Not Fit All

Ayush Kumar, Georgia Stavrakis, Andrew H. Karaba

Summary: Herpesviruses are common DNA viruses that cause lifelong infections and are associated with various diseases. They activate the innate immune system by inflammasome signaling, leading to inflammation and potential disease outcomes.

MBIO (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Does one size fit all? Differences between islands in Tuvalu and ecological perspectives

Po-Jen Lin, Tai-Lin Lee, Chih-Fu Wei, Chih-Wei Shih, Maria Soledad Hershey, Yu-Tien Hsu, Selotia Tausi, Vine Sosene, Pauke P. Maani, Malo Tupulaga, Yuan-Hung Lo

Summary: Stakeholder engagement is crucial in health research as it enhances the quality of research by incorporating diverse perspectives beyond the traditional research team. Funders recognize the benefits of stakeholder engagement on research outcomes and are making it mandatory in grant applications. Stakeholder engagement helps improve community health, knowledge, and well-being by reducing ambiguity in research findings and increasing early acceptance.

JOURNAL OF GLOBAL HEALTH (2022)

Add to Collection

Review Urology & Nephrology

Measuring albuminuria or proteinuria: does one answer fit all?

Tyrone G. Harrison, Marcello Tonelli

Summary: The measurement of proteinuria is crucial for diagnosing and monitoring kidney disease, but there is still controversy and uncertainty surrounding the optimal measurement method. International guidelines recommend the use of urinary albumin-to-creatinine ratio, but this method is not universally available and can be costly. Additionally, the accuracy of different measurement methods may vary depending on the magnitude of albuminuria, sex, and clinical contexts.

KIDNEY INTERNATIONAL (2023)

Add to Collection

Article Endocrinology & Metabolism

Surgical treatment of tertiary hyperparathyroidism: does one fit for all?

Claudio Casella, Claudio Guarneri, Manuela Campanile, Xavier Adhoute, Pier Paolo Gelera, Riccardo Morandi

Summary: The study found that in patients treated with TPTX-AT or SPTX for 3HPT, the TPTX-AT group had lower plasma calcium concentrations compared to the SPTX group throughout the follow-up period, always remaining within the normal range. There was no significant difference between the two groups in terms of the persistence/recurrence of disease, incidence of transitory hypocalcemia, and temporary/permanent hypoparathyroidism.

FRONTIERS IN ENDOCRINOLOGY (2023)

Add to Collection

Review Medicine, General & Internal

Inflammatory Bowel Diseases: Does One Histological Score Fit All?

Vincenzo Villanacci, Rachele Del Sordo, Tommaso Lorenzo Parigi, Giuseppe Leoncini, Gabrio Bassotti

Summary: Mucosal healing (MH) is the main target for treating ulcerative colitis (UC) and Crohn's disease, with neutrophil infiltration being a key histological marker. Existing histological scoring systems for assessing disease severity are complex and subjective. Simplified mucosal healing schemes based on neutrophils and their distribution show advantages. Future developments include standardization with artificial intelligence models and new molecular markers for inflammation in diagnostic practice.

DIAGNOSTICS (2023)

Add to Collection

Article Plant Sciences

One size does not fit all: The complex relationship between biodiversity and psychological well-being

Assaf Shwartz, Maya Tzunz, Lee Gafter, Agathe Colleony

Summary: Conserving urban biodiversity is important for aligning public health and biodiversity conservation agendas. However, research shows that the relationship between biodiversity and psychological well-being is complex and depends on factors such as nature relatedness and ecological knowledge. A study conducted in Israel found that psychological well-being was associated with woody species cover and perceived species richness, and this relationship was moderated by nature relatedness. Designing urban green spaces that foster emotional affinity to nature is crucial for sustainable urban planning.

URBAN FORESTRY & URBAN GREENING (2023)

Add to Collection

Review Cell Biology

One Size Does Not Fit All: Heterogeneity in Developmental Hematopoiesis

Cristiana Barone, Roberto Orsenigo, Raffaella Meneveri, Silvia Brunelli, Emanuele Azzoni

Summary: Our understanding of the complexity of the developing hematopoietic system has greatly increased in recent decades. We now know that multiple HSC-independent progenitor populations during fetal development play vital roles that can affect adult physiology and lead to disease. Ontogeny has been shown to be a primary determinant of the function of critical cell types.

CELLS (2022)

Add to Collection

Article Computer Science, Hardware & Architecture

Graph partitioning strategies: one size does not fit all

Xiaomeng Zhai, Hong Zhang, Xu Huang, Shouhua Zhang

Summary: This paper focuses on the problem of graph partitioning in distributed graph computing. The existing graph partitioning methods do not consider the relationship between partition strategies and graph algorithm characteristics, resulting in significant performance differences. To address this issue, the paper proposes a distributed graph partitioning framework based on program analysis, which can select the optimal partitioning strategy based on the characteristics of the graph algorithm. Additionally, the paper introduces a triangle-based partitioning strategy and redesigns the PageRank algorithm to reduce shuffling operations. Experimental results show that the proposed adaptive graph partitioning framework outperforms the original framework, especially in triangle counting and PageRank algorithms, on both real-world and synthetic graphs.

JOURNAL OF SUPERCOMPUTING (2022)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Pacing or ablation for vasovagal syncope: one size does not fit all

Tolga Aksu, Carlos A. Morillo, Richard Sutton

Summary: This article describes a practical decision pathway for managing vasovagal syncope, including the locations of autonomic ganglia and methods for evaluating the response to treatment.

EUROPEAN HEART JOURNAL (2023)

Add to Collection

Article Oncology

Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up

P. Roth, A. Pace, E. Le Rhun, M. Weller, C. Ay, E. Cohen-Jonathan Moyal, M. Coomans, R. Giusti, K. Jordan, R. Nishikawa, F. Winkler, J. T. Hong, R. Ruda, S. Villa, M. J. B. Taphoorn, W. Wick, M. Preusser

ANNALS OF ONCOLOGY (2021)

Add to Collection

Review Oncology

Standard of Care and Promising New Agents for the Treatment of Mesenchymal Triple-Negative Breast Cancer

Silvia Mezi, Andrea Botticelli, Giulia Pomati, Bruna Cerbelli, Simone Scagnoli, Sasan Amirhassankhani, Giulia d'Amati, Paolo Marchetti

Summary: The mesenchymal triple negative breast cancer subtype is characterized by the expression of specific genes and an immunosuppressive microenvironment. Research focuses on the intracellular pathways involved in tumorigenesis and cancer progression, as well as strategies to address immune evasion mechanisms.

CANCERS (2021)

Add to Collection

Article Oncology

Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation

Marco Russano, Alessio Cortellini, Raffaele Giusti, Alessandro Russo, Federica Zoratto, Francesca Rastelli, Alain Gelibter, Rita Chiari, Olga Nigro, Michele De Tursi, Sergio Bracarda, Stefania Gori, Francesco Grossi, Melissa Bersanelli, Lorenzo Calvetti, Vincenzo Di Noia, Mario Scartozzi, Massimo Di Maio, Paolo Bossi, Alfredo Falcone, Fabrizio Citarella, Francesco Pantano, Corrado Ficorella, Marco Filetti, Vincenzo Adamo, Enzo Veltri, Federica Pergolesi, Mario Alberto Occhipinti, Linda Nicolardi, Alessandro Tuzi, Pietro Di Marino, Serena Macrini, Alessandro Inno, Michele Ghidini, Sebastiano Buti, Giuseppe Aprile, Eleonora Lai, Marco Audisio, Salvatore Intagliata, Riccardo Marconcini, Davide Brocco, Giampiero Porzio, Marta Piras, Erika Rijavec, Francesca Simionato, Clara Natoli, Marcello Tiseo, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini

Summary: The study did not find a survival benefit in patients experiencing severe irAEs compared to the control group. However, early and severe irAEs may indicate immune anti-tumor activation, and there was a significant association with first-line immune checkpoint inhibitors treatment and good patient performance status. Further research is needed on risk prediction and management of serious and early irAEs in NSCLC patients.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)

Add to Collection

Article Oncology

A 17-Gene Expression Signature for Early Identification of Poor Prognosis in Clear Cell Renal Cell Carcinoma

Maria Bassanelli, Marina Borro, Michela Roberto, Diana Giannarelli, Silvana Giacinti, Simona Di Martino, Anna Ceribelli, Andrea Russo, Annamaria Aschelter, Stefania Scarpino, Andrea Montori, Edoardo Pescarmona, Silverio Tomao, Maurizio Simmaco, Francesco Cognetti, Michele Milella, Paolo Marchetti

Summary: Our analysis identified a 17-gene expression signature that can predict the prognosis of patients with clear cell renal cancer. These genomic signatures have a significant correlation with overall survival and could potentially be used as biomarkers for prognosis prediction in ccRCC.

CANCERS (2022)

Add to Collection

Article Oncology

Patients' Satisfaction with Breakthrough Cancer Pain Therapy: A Secondary Analysis of IOPS-MS Study

Marco Mazzotta, Marco Filetti, Marta Piras, Sebastiano Mercadante, Paolo Marchetti, Raffaele Giusti

Summary: This study aims to identify factors that can predict patients' satisfaction with pain relief for breakthrough cancer pain (BTcP). The results showed that younger age, non metastatic cancer stage, high Karnofsky performance status, absence of anticancer treatment, and high BTcP interference in activities of daily living were positively correlated with dissatisfaction.

CANCER MANAGEMENT AND RESEARCH (2022)

Add to Collection

Review Oncology

Definition of High-Risk Early Hormone-Positive HER2-Negative Breast Cancer: A Consensus Review

Mattia Garutti, Gaia Griguolo, Andrea Botticelli, Giulia Buzzatti, Carmine De Angelis, Lorenzo Gerratana, Chiara Molinelli, Vincenzo Adamo, Giampaolo Bianchini, Laura Biganzoli, Giuseppe Curigliano, Michelino De Laurentiis, Alessandra Fabi, Antonio Frassoldati, Alessandra Gennari, Caterina Marchio, Francesco Perrone, Giuseppe Viale, Claudio Zamagni, Alberto Zambelli, Lucia Del Mastro, Sabino De Placido, Valentina Guarneri, Paolo Marchetti, Fabio Puglisi

Summary: Breast cancer is a leading cause of cancer-related morbidity and mortality in women worldwide, and estimating the risk of relapse for individual cases remains challenging. The IRIDE working group reviewed literature evidence to identify the relevant features predicting relapse in hormone receptor-positive/HER2-negative early breast cancer, aiming to provide guidance for clinicians in managing these cases effectively.

CANCERS (2022)

Add to Collection

Article Oncology

The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+Breast Cancer: The TRISKELE Multicenter Prospective Study

Eriseld Krasniqi, Francesca Sofia Di Lisa, Anna Di Benedetto, Maddalena Barba, Laura Pizzuti, Lorena Filomeno, Cristiana Ercolani, Nicola Tinari, Antonino Grassadonia, Daniele Santini, Mauro Minelli, Filippo Montemurro, Maria Agnese Fabbri, Marco Mazzotta, Teresa Gamucci, Giuliana D'Auria, Claudio Botti, Fabio Pelle, Flavia Cavicchi, Sonia Cappelli, Federico Cappuzzo, Giuseppe Sanguineti, Silverio Tomao, Andrea Botticelli, Paolo Marchetti, Marcello Maugeri-Sacca, Ruggero De Maria, Gennaro Ciliberto, Francesca Sperati, Patrizia Vici

Summary: This study investigated the impact of immunohistochemical expression of Hippo pathway transducers and cell metabolism regulators on the outcome of neoadjuvant treatment in Her2+ breast cancer patients. The results showed that low expression of TAZ, especially when combined with low expression of YAP and HMGCR and high expression of SCD1, may be a negative predictor of treatment response. However, further studies with a larger sample size are needed to validate these findings.

CANCERS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Genomic and Immune Approach in Platinum Refractory HPV-Negative Head and Neck Squamous Cell Carcinoma Patients Treated with Immunotherapy: A Novel Combined Profile

Silvia Mezi, Giulia Pomati, Ilaria Grazia Zizzari, Alessandra Di Filippo, Bruna Cerbelli, Alessio Cirillo, Giulia Fiscon, Sasan Amirhassankhani, Valentino Valentini, Marco De Vincentiis, Alessandro Corsi, Cira Di Gioia, Vincenzo Tombolini, Carlo Della Rocca, Antonella Polimeni, Marianna Nuti, Paolo Marchetti, Andrea Botticelli

Summary: This study evaluated the combined role of genomic and immune profiles in PR/HNSCC patients treated with anti-PD-1 nivolumab. The results showed that some patients benefited from the treatment, while others experienced early progression. Furthermore, specific gene mutations and immune features were found to be associated with treatment response.

BIOMEDICINES (2022)

Add to Collection

Article Oncology

Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement

Vincenzo Adamo, Lorenzo Antonuzzo, Marco Danova, Michelino De Laurentiis, Paolo Marchetti, Carmine Pinto, Giovanni Rosti

Summary: This study aims to improve adherence to guideline recommendations for the prevention of febrile neutropenia and to enhance patient care.

SUPPORTIVE CARE IN CANCER (2022)

Add to Collection

Article Oncology

The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO Study

Maurizio Muscaritoli, Alessandra Modena, Matteo Valerio, Paolo Marchetti, Roberto Magarotto, Silvia Quadrini, Filomena Narducci, Giuseppe Tonini, Teresa Grassani, Luigi Cavanna, Camilla Di Nunzio, Chiara Citterio, Marcella Occelli, Antonia Strippoli, Bruno Chiurazzi, Antonio Frassoldati, Giuseppe Altavilla, Antonio Lucenti, Fabrizio Nicolis, Stefania Gori

Summary: Malnutrition and cachexia in cancer patients have a negative impact on treatment, outcomes, quality of life, and survival. However, the risk of malnutrition and cachexia is still overlooked in cancer patients. A study revealed that 51% of patients already had nutritional deficiencies at their first oncology visit. These findings emphasize the importance of proactive, early management of malnutrition in cancer patients.

CANCERS (2023)

Add to Collection

Article Health Care Sciences & Services

Palliative sedation and time to death in home palliative care: retrospective analysis

Daniele Marinelli, Giulio Ravoni, Maria Fusilli, Emilia Colpani, Marco Filetti, Daniele Santini, Giampiero Porzio, Raffaele Giusti

Summary: This study examined time to death and rates of palliative sedation in home palliative care for patients with advanced cancer. The results showed that Eastern Cooperative Oncology Group performance status, sex, and anticancer treatment significantly influenced survival time. Among the cohort, 38% of patients received home palliative sedation for refractory symptoms, primarily delirium and dyspnoea.

BMJ SUPPORTIVE & PALLIATIVE CARE (2023)

Add to Collection

Letter Health Care Sciences & Services

Medical oncologists and supportive/palliative care education: prevention of fragmented care'

Raffaele Giusti, Giulio Ravoni, Giampiero Porzio

BMJ SUPPORTIVE & PALLIATIVE CARE (2023)

Add to Collection

Letter Health Care Sciences & Services

Training and telemedicine: the key to the palliative medicine specialist shortage?

Giulio Ravoni, Maria Fusilli, Giulia Parretti, Emilia Colpani, Giampiero Porzio, Giuseppe Spinelli, Daniele Marinelli, Raffaele Giusti

BMJ SUPPORTIVE & PALLIATIVE CARE (2023)

Add to Collection

Article Medicine, General & Internal

Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study

Melissa Bersanelli, Elena Verzoni, Alessio Cortellini, Raffaele Giusti, Lorenzo Calvetti, Paola Ermacora, Marilena Di Napoli, Annamaria Catino, Valentina Guadalupi, Giorgia Guaitoli, Vieri Scotti, Francesca Mazzoni, Antonello Veccia, Pamela Francesca Guglielmini, Fabiana Perrone, Marco Maruzzo, Ernesto Rossi, Chiara Casadei, Vincenzo Montesarchio, Francesco Grossi, Mimma Rizzo, Maria Grazia Travagliato Liboria, Manlio Mencoboni, Fable Zustovich, Lucia Fratino, Caterina Accettura, Saverio Cinieri, Andrea Camerini, Mariella Soraru, Paolo Andrea Zucali, Serena Ricciardi, Antonio Russo, Giorgia Negrini, Maria Chiara Banzi, Gaetano Lacidogna, Giuseppe Fornarini, Letizia Laera, Claudia Mucciarini, Matteo Santoni, Claudia Mosillo, Andrea Bonetti, Lucia Longo, Donata Sartori, Editta Baldini, Michele Guida, Mauro Iannopollo, Roberto Bordonaro, Maria Francesca Morelli, Pierosandro Tagliaferri, Massimiliano Spada, Anna Ceribelli, Rosa Rita Silva, Franco Nole, Giordano Beretta, Petros Giovanis, Daniele Santini, Stefano Luzi Fedeli, Oriano Nanni, Evaristo Maiello, Roberto Labianca, Carmine Pinto, Alberto Clemente, Michele Tognetto, Ugo De Giorgi, Sandro Pignata, Massimo Di Maio, Sebastiano Buti, Diana Giannarelli

Summary: The INVIDIa-2 study found that influenza vaccination has a positive impact on the outcomes of advanced cancer patients receiving immune checkpoint inhibitor therapy. The vaccination was associated with improved overall survival, progression-free survival, and disease-control rate. These findings support the recommendation of vaccination in cancer patients and suggest a potential synergy between antiviral and antitumor immunity. Rating: 8/10.

ECLINICALMEDICINE (2023)

Add to Collection

Article Oncology

A Regional Survey on Merkel Cell Carcinoma: A Plea for Uniform Patient Journey Modeling and Diagnostic-Therapeutic Pathway

Michela Roberto, Andrea Botticelli, Alessio Caggiati, Alberto Chiriatti, Carlo Della Rocca, Virginia Ferraresi, Felice Musicco, Giovanni Pellacani, Paolo Marchetti

Summary: Merkel cell carcinoma (MCC) is a rare and aggressive skin cancer that affects elderly and immunosuppressed individuals in sun-exposed areas. A survey conducted in the Lazio region, Italy, reveals variations in awareness and knowledge of MCC among different medical specialties. Improving communication and establishing specialized centers can enhance the diagnostic and therapeutic pathways for MCC patients.

CURRENT ONCOLOGY (2022)

Add to Collection

No Data Available

Integration between oncology and palliative care: does one size fit all?

Journal

Publisher

OXFORD UNIV PRESS

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper